Nyheter m m

GlobeNewswire
		

CTI Clinical Trial & Consulting Services: CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

21:00 COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America. The acquisition strengthens CTIs existing Real World Evidence business, adding significant presence and expertise in Europe and Latin America. Eurotrials has offices in Argentina, Brazil, Chile, Mexico, Peru, Portugal and Spain, covering over 15 countries in both regions. Eurotrials provides an extensive array of services from early- to late-stage research as well as product support in accordance with global and specific regional requirements. Additionally, the Eurotrials footprint augments CTIs current reach, enabling CTI to better serve clients and global programs. We are excited to join our companies together to create a stronger full-service global clinical research organization, according to Timothy J. Schroeder, CTI Founder and CEO. This combined company will be one of the 20 largest CROs in the world, with associates in more than 30 countries across six continents. We believe this combined entity is the oldest, largest, privately owned CRO in the world with the founders still active in the company operations. Were also thrilled that the leaders of Eurotrials, Maria Joo Queiroz and Ins Costa, will continue to play a large role in the organization. We are very pleased with the opportunity to combine strengths and expertise with CTI, according to Maria Joo Queiroz, MD, Founder and CEO of Eurotrials. Our companies have a strong cultural fit and a similar approach to clients and collaborators. Joining CTI enhances the access our clients have to industry leading therapeutic expertise, a broader global footprint, and a greater capacity for innovative solutions, while still maintaining focus on the local and regional proximity to our clients, as well as the quality and customer service that is highly valued by Eurotrials clients. The terms of the acquisition were not disclosed. Plante Moran and Fifth Third Bank provided support to CTI throughout the acquisition. About CTI Clinical Trial and Consulting Services CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization, including real world evidence. CTIs focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com Media Contact: Allison Schroeder 513.598.9290 aschroeder@ctifacts.com --------------------------------------- This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: CTI Clinical Trial&Consulting Services via Globenewswire © GlobeNewswire
FooterBanner

Finansiella instrument kan både öka och minska i värde. Det finns en risk att du inte får tillbaka de pengar du investerar. Innan du investerar i en fond bör du läsa informationsbroschyren som finns hos fondbolaget och faktabladet som du hittar i orderläggningsfönstret samt på fondens produktsida på nordnet.se.